Oropharyngeal Squamous Cell Carcinoma

Oncology·MeSH: Squamous Cell Carcinoma of Head and Neck

6 drugs in development·5 companies·6 clinical trials

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
ozuriftamab vedotin	BioAtla, Inc. (BCAB)

Phase 2(2)

Drug	Company
had5-hpv vaccine	ImmunityBio, Inc. (IBRX)
ino-3112	INOVIO PHARMACEUTICALS, INC. (INO)

Phase 1(2)

Drug	Company
APR-1051	Aprea Therapeutics, Inc. (APRE)
nogapendekin alfa inbakicept	ImmunityBio, Inc. (IBRX)

Phase 2/Phase 3(1)

Drug	Company
hb-202/hb-201 alternating 2-vector therapy	HOOKIPA Pharma Inc. (HOOK)

BioSniper tracks 6 drugs in development for Oropharyngeal Squamous Cell Carcinoma across 5 companies.

There are 6 clinical trials targeting Oropharyngeal Squamous Cell Carcinoma tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.